📈 Market Data
A pricing and market intelligence database for peptide (peptide-based) APIs and intermediates, covering price trends, supply-demand analysis, import-export trade data, and corporate financial benchmarking. Data is sourced from the General Administration of Customs, industry associations, and publicly listed company filings, updated monthly/quarterly.
📋 Data Sections Overview
| Section |
Core Content |
Update Frequency |
Data Coverage |
| Peptide API Pricing Trends |
Pricing by chain length (short/medium/long), purity grades, historical price comparisons |
Quarterly |
2022–2026 |
| Supply-Demand Dynamics |
Capacity utilization, demand growth, GLP-1-driven supply tightness |
Semi-annual |
2020–2026 |
| Import-Export Data |
China peptide API trade values, destination distribution, trade policy impacts |
Annual |
2020–2024 |
| Company Revenue Benchmarking |
Financial metrics for leading peptide companies (revenue, gross margin, R&D, market cap) |
Annual |
FY2024 |
🔑 Key Pricing Benchmark Summary
API Price Benchmarks by Peptide Chain Length (2024–2025 Average)
| Peptide Category |
Amino Acid Range |
Research Grade <95% |
GMP Grade ≥95% |
GMP Grade ≥98% |
6-Month Trend |
| Short-Chain |
3–10 aa |
$850–1,200/kg |
$2,500–4,000/kg |
$5,000–8,000/kg |
⬇️ Declining |
| Medium-Chain |
10–30 aa |
$5,000–8,000/kg |
$8,000–15,000/kg |
$15,000–25,000/kg |
➡️ Stable |
| Long-Chain |
30–50 aa |
$20,000–35,000/kg |
$45,000–80,000/kg |
$80,000–150,000/kg |
⬆️ Rising |
| Extra-Long Chain |
>50 aa |
$80,000–150,000/kg |
$150,000–300,000/kg |
$300,000+/kg |
⬆️ Rising |
GLP-1 API Special Pricing Reference (2025 Q2)
| API Product |
Purity Specification |
Reference Price Range |
Trend |
Key Suppliers |
| Semaglutide Intermediate (7.1–7.2 aa) |
Industrial Grade |
$8,000–12,000/kg |
➡️ Stable |
Sinopeptide, Hybio |
| Semaglutide API (≥99%) |
GMP |
$180,000–250,000/kg |
⬇️ Declining |
Sinopeptide, WuXi AppTec |
| Tirzepatide API (≥99%) |
GMP |
$200,000–300,000/kg |
➡️ Elevated |
WuXi AppTec, Asymchem |
| Liraglutide API (≥99%) |
GMP |
$5,000–10,000/kg |
⬇️ Declining |
Multiple domestic suppliers |
GLP-1 API Pricing Outlook
Semaglutide API has been declining since Q4 2024 (from $300,000+/kg down to $180,000–250,000/kg). Key drivers: (1) increased supply from China CDMO capacity additions; (2) process optimization reducing production costs at multiple firms; (3) scale effects from early capacity lock-in agreements by generic manufacturers. A further 30–50% decline is expected by 2026–2027 as patents expire and new capacity comes online.
📊 Market Data Overview — Quick Reference
Global Peptide API Market Key Indicators
| Metric |
Latest Value |
2023 |
2024 |
2025E |
Trend |
| Global Peptide API Market Size ($B) |
~$15.0 |
$13.2 |
$15.0 |
$17.5 |
⬆️ Growth |
| China Peptide API Market Size (¥B) |
~¥12.8 |
¥11.7 |
¥12.8 |
¥14.2 |
⬆️ Growth |
| China API Export Total ($B) |
$1.82 (2024) |
$1.58 |
$1.82 |
$2.05E |
⬆️ Growth |
| Global API Capacity Utilization |
~92% |
88% |
92% |
95%+E |
⬆️ Tightening |
| China API Share of Global Capacity |
~38% |
36% |
38% |
40%+E |
⬆️ Rising |
China Peptide API Export Destination Breakdown (2024)
| Destination |
Export Share |
Export Value ($M) |
YoY Change |
Key Product Types |
| North America (US + Canada) |
35% |
~$637 |
+18% YoY |
GLP-1 APIs, Cosmetic Peptides |
| Europe (EU + UK + Switzerland) |
28% |
~$510 |
+12% YoY |
Generic APIs, Cosmetic Peptides |
| Southeast Asia + India |
15% |
~$273 |
+22% YoY |
Short-Chain Peptides, Liraglutide API |
| Japan + South Korea |
10% |
~$182 |
+8% YoY |
High-Purity Custom Peptides |
| Other Regions |
12% |
~$218 |
+15% YoY |
Diversified |
Global CDMO Capacity Utilization and Expansion
| CDMO |
SPPS Capacity |
2025 Planned Capacity |
Utilization Rate |
GMP Certifications |
Country |
| WuXi AppTec |
40,000L → 60,000L |
60,000L |
>95% |
FDA, EU, NMPA, PMDA |
China |
| Bachem |
~30,000L |
35,000L |
>90% |
FDA, EU |
Switzerland |
| PolyPeptide |
~25,000L |
28,000L |
>85% |
FDA, EU |
Belgium |
| Sinopeptide |
2,000 kg/yr → 5,000 kg/yr |
5,000 kg/yr |
>95% |
NMPA, FDA |
China |
| Shenggene |
1,500 kg/yr |
2,500 kg/yr |
>85% |
NMPA |
China |
| Asymchem |
~5,000L |
8,000L |
>90% |
NMPA |
China |
📊 Data Sources and Methodology
Data Collection Notes
All pricing data in this section is compiled from:
- Public quotation platforms: Median quotes from Yaozhi.com, Chemical Book, Guidechem
- Corporate annual reports: API revenue and volume data reverse-calculated from listed company filings
- Customs data: China General Administration of Customs HS codes 2937 (peptide hormones) and 2934 (other peptides)
- Industry reports: Frost & Sullivan, Grand View Research peptide API reports
- CDMO quotations: Public price lists and RFP feedback from leading CDMOs
Price ranges represent ±20% of median transaction prices at each tier and are not spot quotes. For real-time pricing, please contact suppliers directly. Data updates are quarterly; the next full refresh is scheduled for October 2026.
Pricing Influencing Factors
| Factor |
Impact on Price |
Explanation |
| Peptide Chain Length |
⬆️ Positive correlation |
Each additional 10 aa increases synthesis difficulty and cost by approximately 3–5× |
| Purity Requirement |
⬆️ Positive correlation |
Upgrading from 95% to 98% purity typically adds 50–100% premium |
| GMP Grade |
⬆️ Positive correlation |
GMP-grade commands 2–5× premium over research grade |
| Sequence Complexity |
⬆️ Positive correlation |
D-amino acids, non-natural AAs, cyclization increase difficulty |
| Purchase Volume |
⬇️ Negative correlation |
kg-scale vs. g-scale reduces unit price by 40–70% |
| Supply-Demand Balance |
⬆️⬇️ Bidirectional |
GLP-1 APIs carry significant premium due to supply constraints |
📞 Custom Data Services: Need more detailed API pricing data sets, historical price curves, or corporate benchmarking reports? Reach out to SENO Biotechnology for tailored industry intelligence solutions and custom analytics.